Procaps Group S.A. (PROC) Financial Analysis & Valuation | Quarter Chart
Procaps Group S.A. (PROC)
PROCPrice: $1.01
Fair Value: 🔒
🔒score
Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardio... more
Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company f... more
Description
Shares
| Market Cap | $102.08M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Country | LU | CEO | Jose Antonio Toledo Vieira |
| IPO Date | 2019-12-09 | CAGR | 0.08% |
| Employees | 5,500 | Website | www.procapsgroup.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 0.83% | Total Yield | 0.83% |
PROC chart loading...
Fundamentals
Technicals
| Enterprise Value | $631.27M | P/E Ratio | 1.53 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 0.28 | P/B Ratio | -108.52 |
| P/CF Ratio | 7.24 | P/FCF Ratio | -6.52 |
| EPS | $0.66 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | -4.8% | Gross Margin | 0.58% |
| Operating Margin | 0.13% | Profit Margin | 0.1% |
| ROE | -2.22% | ROA | 0.09% |
| ROCE | 0.57% | Current Ratio | 0.81 |
| Quick Ratio | 0.54 | Cash Ratio | 0.12 |
| Debt/Equity | -303.86 | Interest Coverage | 2.03 |
| Altman Z Score | 0.79 | Piotroski Score | 5 |